Given Sobi's cash flow generation from its hemophilia business and mature product Synagis, the firm ended 2024 with a net debt/EBITDA ratio of 1.6 times. We expect the firm can support this level of ...

Influenza A virus particles strategically adapt their shape—to become either spheres or larger filaments—to favor their ...

Research published in late 2024 in the journal JAMA Pediatrics found nirsevimab was more than 90 percent effective at preventing hospitalization for RSV, and 89 percent effective at preventing all ...

AIM Vaccine Co., Ltd., a leading PRC vaccine company, announced today that its independently developed mRNA RSV (respiratory syncytial virus) vaccine has recently been submitted for clinical trials to ...

A nationwide surge in flu, COVID-19, RSV and norovirus infections is fueling concerns of a possible virus "quademic." Or is it just winter? The three respiratory viruses plus norovirus ...

there is some COVID-19 and respiratory syncytial virus infections mixed in, as well, Baker said. At Trident Health System, "we’re experiencing a higher than average incidence of patients with ...

8,9,10 A published modeling study on hospitalizations related to RSV shows that chronic respiratory and heart diseases, as well as diabetes, are common among patients admitted for the virus.

Flu, RSV and other respiratory illnesses are sending people to urgent care and emergency rooms. In some cases, these patients are ending up with pneumonia. Flu, RSV and other respiratory illnesses are ...

For all patients infected with IAV, IBV, or RSV, more than 60% of index cases and secondary cases had received the seasonal flu vaccine. Having a school-age child (under the age of 18) as an index ...

AstraZeneca and Sanofi have secured approval in the EU for Beyfortus, the first single-dose drug to protect newborns and infants from respiratory syncytial virus (RSV) infections. The antibody ...